The global Pertussis Vaccination market size was valued at US$ 5728 million in 2024 and is forecast to a readjusted size of USD 7228 million by 2031 with a CAGR of 3.4% during review period.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71鈥�85% effective.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Pertussis Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pertussis Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pertussis Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pertussis Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pertussis Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pertussis Vaccination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pertussis Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Pertussis Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Acellular Vaccines
Whole-cell Vaccines
麻豆原创 segment by Application
12 Months Below
12 Months Above
Major players covered
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pertussis Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pertussis Vaccination, with price, sales quantity, revenue, and global market share of Pertussis Vaccination from 2020 to 2025.
Chapter 3, the Pertussis Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertussis Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pertussis Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pertussis Vaccination.
Chapter 14 and 15, to describe Pertussis Vaccination sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Pertussis Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Acellular Vaccines
1.3.3 Whole-cell Vaccines
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Pertussis Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 12 Months Below
1.4.3 12 Months Above
1.5 Global Pertussis Vaccination 麻豆原创 Size & Forecast
1.5.1 Global Pertussis Vaccination Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pertussis Vaccination Sales Quantity (2020-2031)
1.5.3 Global Pertussis Vaccination Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Pertussis Vaccination Product and Services
2.1.4 Sanofi Pasteur Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pertussis Vaccination Product and Services
2.2.4 GSK Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 GSK Recent Developments/Updates
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Product and Services
2.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.4 KM Biologics
2.4.1 KM Biologics Details
2.4.2 KM Biologics Major Business
2.4.3 KM Biologics Pertussis Vaccination Product and Services
2.4.4 KM Biologics Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 KM Biologics Recent Developments/Updates
2.5 Wuhan Institute of Biological Products
2.5.1 Wuhan Institute of Biological Products Details
2.5.2 Wuhan Institute of Biological Products Major Business
2.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Product and Services
2.5.4 Wuhan Institute of Biological Products Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology Pertussis Vaccination Product and Services
2.6.4 Walvax Biotechnology Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Walvax Biotechnology Recent Developments/Updates
2.7 Chengdu Institute of Biological Products
2.7.1 Chengdu Institute of Biological Products Details
2.7.2 Chengdu Institute of Biological Products Major Business
2.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Product and Services
2.7.4 Chengdu Institute of Biological Products Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.8 Minhai Biotechnology
2.8.1 Minhai Biotechnology Details
2.8.2 Minhai Biotechnology Major Business
2.8.3 Minhai Biotechnology Pertussis Vaccination Product and Services
2.8.4 Minhai Biotechnology Pertussis Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Minhai Biotechnology Recent Developments/Updates
3 Competitive Environment: Pertussis Vaccination by Manufacturer
3.1 Global Pertussis Vaccination Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pertussis Vaccination Revenue by Manufacturer (2020-2025)
3.3 Global Pertussis Vaccination Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Pertussis Vaccination by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Pertussis Vaccination Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Pertussis Vaccination Manufacturer 麻豆原创 Share in 2024
3.5 Pertussis Vaccination 麻豆原创: Overall Company Footprint Analysis
3.5.1 Pertussis Vaccination 麻豆原创: Region Footprint
3.5.2 Pertussis Vaccination 麻豆原创: Company Product Type Footprint
3.5.3 Pertussis Vaccination 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pertussis Vaccination 麻豆原创 Size by Region
4.1.1 Global Pertussis Vaccination Sales Quantity by Region (2020-2031)
4.1.2 Global Pertussis Vaccination Consumption Value by Region (2020-2031)
4.1.3 Global Pertussis Vaccination Average Price by Region (2020-2031)
4.2 North America Pertussis Vaccination Consumption Value (2020-2031)
4.3 Europe Pertussis Vaccination Consumption Value (2020-2031)
4.4 Asia-Pacific Pertussis Vaccination Consumption Value (2020-2031)
4.5 South America Pertussis Vaccination Consumption Value (2020-2031)
4.6 Middle East & Africa Pertussis Vaccination Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Pertussis Vaccination Sales Quantity by Type (2020-2031)
5.2 Global Pertussis Vaccination Consumption Value by Type (2020-2031)
5.3 Global Pertussis Vaccination Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Pertussis Vaccination Sales Quantity by Application (2020-2031)
6.2 Global Pertussis Vaccination Consumption Value by Application (2020-2031)
6.3 Global Pertussis Vaccination Average Price by Application (2020-2031)
7 North America
7.1 North America Pertussis Vaccination Sales Quantity by Type (2020-2031)
7.2 North America Pertussis Vaccination Sales Quantity by Application (2020-2031)
7.3 North America Pertussis Vaccination 麻豆原创 Size by Country
7.3.1 North America Pertussis Vaccination Sales Quantity by Country (2020-2031)
7.3.2 North America Pertussis Vaccination Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Pertussis Vaccination Sales Quantity by Type (2020-2031)
8.2 Europe Pertussis Vaccination Sales Quantity by Application (2020-2031)
8.3 Europe Pertussis Vaccination 麻豆原创 Size by Country
8.3.1 Europe Pertussis Vaccination Sales Quantity by Country (2020-2031)
8.3.2 Europe Pertussis Vaccination Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Pertussis Vaccination Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pertussis Vaccination Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pertussis Vaccination 麻豆原创 Size by Region
9.3.1 Asia-Pacific Pertussis Vaccination Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pertussis Vaccination Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Pertussis Vaccination Sales Quantity by Type (2020-2031)
10.2 South America Pertussis Vaccination Sales Quantity by Application (2020-2031)
10.3 South America Pertussis Vaccination 麻豆原创 Size by Country
10.3.1 South America Pertussis Vaccination Sales Quantity by Country (2020-2031)
10.3.2 South America Pertussis Vaccination Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Pertussis Vaccination Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pertussis Vaccination Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pertussis Vaccination 麻豆原创 Size by Country
11.3.1 Middle East & Africa Pertussis Vaccination Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pertussis Vaccination Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Pertussis Vaccination 麻豆原创 Drivers
12.2 Pertussis Vaccination 麻豆原创 Restraints
12.3 Pertussis Vaccination Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pertussis Vaccination and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pertussis Vaccination
13.3 Pertussis Vaccination Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pertussis Vaccination Typical Distributors
14.3 Pertussis Vaccination Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
听
听
*If Applicable.
